$0.69
-0.0419[-5.72%]
At close: Apr 18
$0.69
0[0.00%]
After Hours: 4:00PM EDT
Cara Therapeutics
(NASDAQ:CARA)Cara Therapeutics Stock (NASDAQ:CARA), Quotes and News Summary
Cara Therapeutics Stock (NASDAQ: CARA) stock price, news, charts, stock research, profile.
| Open | $0.730 |
| Close | $0.690 |
| Volume / Avg. | 363.143K / 659.446K |
| Day Range | 0.680 - 0.736 |
| 52 Wk Range | 0.500 - 4.670 |
| Market Cap | $37.713M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 38 |
| Short Interest | 6.57% |
| Days to Cover | 5.87 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Cara Therapeutics Inc
Sector
Health Care
Industry
Pharmaceuticals
Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of no...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cara Therapeutics (CARA) stock?
You can purchase shares of Cara Therapeutics (NASDAQ: CARA) through any online brokerage.
Who are Cara Therapeutics's (CARA) competitors?
Other companies in Cara Therapeutics’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), SCYNEXIS (NASDAQ:SCYX), Jaguar Health (NASDAQ:JAGX) and Ocuphire Pharma (NASDAQ:OCUP).
What is the target price for Cara Therapeutics (CARA) stock?
The latest price target for Cara Therapeutics (NASDAQ: CARA) was reported by Needham on Wednesday, April 10, 2024. The analyst firm set a price target for 5.00 expecting CARA to rise to within 12 months (a possible 624.64% upside). 16 analyst firms have reported ratings in the last year.
Current Stock Price for Cara Therapeutics (CARA)?
The stock price for Cara Therapeutics (NASDAQ: CARA) is $0.69 last updated April 18, 2024 at 4:00 PM EDT.
Does Cara Therapeutics (CARA) pay a dividend?
There are no upcoming dividends for Cara Therapeutics.
When is Cara Therapeutics (NASDAQ:CARA) reporting earnings?
Cara Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.
Is Cara Therapeutics (CARA) going to split?
There is no upcoming split for Cara Therapeutics.
What sector and industry does Cara Therapeutics (CARA) operate in?
Cara Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.